Teva reaches proposed $4.35 billion settlement of US opioid lawsuits - CNN
Teva stock plummets 18% after rough quarter in US generic drug market
Israel's Teva reaches proposed $4.35 bln settlement of U.S. opioid lawsuits
Teva could pay $3.6b to settle opioid dispute - report - Globes
A sign bearing the logo of Teva Pharmaceutical Industries is seen in its Jerusalem oral solid dosage plant (OSD) December 21, 2011. Israel-based Teva is the world's leading generic drugmaker. REUTERS/Ronen Zvulun (
/s3.amazonaws.com/arc-authors/reuters/95edf7b8-0bf7-4687-a004-a26423a1aae0.png "Teva Pharmaceutical Industries Ltd.")
Teva Pharmaceutical Industries Ltd.
San Francisco reaches $58 million opioid settlement with Teva, Allergan By Reuters
West Virginia Says J&J, Teva, AbbVie Caused 'Tsunami' Of Opioid Addiction: Reuters | Markets Insider
San Francisco reaches $58 mln opioid settlement with Teva, Allergan | Reuters
Exclusive: Teva poised to raise its stake in Mylan - sources
Shloma Yanai, CEO of Teva Pharmaceutical Industries Ltd. collects his papers following a news conference in Cologne March 18, 2010. Teva Pharmaceutical on Thursday bought German generic pharma maker Ratiopharm for 3.625
Teva Reaches Tentative $4.25 Billion Settlement Over Opioids - The New York Times
Teva settles shareholder lawsuit over generic drug | Business Insurance
/s3.amazonaws.com/arc-authors/reuters/75c45489-f2d2-466a-9429-aeeb9ef3b6f1.png "Drugmaker Teva fueled opioid addiction in New York, jury finds | Reuters")
Drugmaker Teva fueled opioid addiction in New York, jury finds | Reuters
Teva stock plummets 18% after rough quarter in US generic drug market
/cloudfront-us-east-2.images.arcpublishing.com/reuters/LZGVDDQWGFNKPLS2GEX4W3DBA4.jpg "Teva lied about opioid role, New York says | Reuters")
Teva lied about opioid role, New York says | Reuters
GSK's $235 million verdict revived against Teva, again | Reuters
Teva, Allergan reach $161.5 million opioid settlement with West Virginia - The Jerusalem Post
TEVA stock lower as company eyes up to $3.6 billion to settle opioid claims - Reuters | Seeking Alpha
Teva's Benign Opioid Settlement Isn't in the Bag Yet - WSJ
Teva Pharmaceutical Industries' new CEO Jeremy Levin speaks during a news conference in Tel Aviv May 9, 2012. Teva Pharmaceutical Industries posted a 40 percent jump in quarterly profit that beat estimates,
Teva, Texas strike opioid settlement worth $225M | Business Insurance
